This article is included in these additional categories: Biological Weapons | Medical | R&D - Contracted | Small Business | USA | WMD Defenses
$6M for Intercellular Bio-agent Countermeasures
For more on this and other stories, please consider purchasing a membership.
If you are already a subscriber, login to your account.
If you are already a subscriber, login to your account.
Genetic Chemistry, Inc. in Palo Alto, CA received a $6 million cost-plus-fixed-fee contract for “research to develop countermeasures to an intercellular bio threat agent.” Work will be performed in Palo Alto, CA and is expected to be complete by July 28/11. Multiple bids were solicited in October 2006, and 1 bid was received by the Research, Development & Engineering Command Acquisition Center in Research Triangle Park, NC (W911NF-08-C-0023).
One Source: Hundreds of programs; Thousands of links, photos, and analyses
DII brings a complete collection of articles with original reporting and research, and expert analyses of events to your desktop – no need for multiple modules, or complex subscriptions. All supporting documents, links, & appendices accompany each article.
Benefits
- Save time
- Eliminate your blind spots
- Get the big picture, quickly
- Keep up with the important facts
- Stay on top of your projects or your competitors
Features
- Coverage of procurement and doctrine issues
- Timeline of past and future program events
- Comprehensive links to other useful resources
Monthly
$59.95/Per Month
- Charged Monthly
- 1 User
Quarterly
$50/Per Month
- $150 Charged Each Quarter
- 1 User
Yearly
$45/Per Month
- $540 charged each year
- 1 User
2 years
$35/Per Month
- $840 Charged every other year
- 1 User